Latest Stock Buy or Sell?
Make More Informed Decisions!

Market Outlook Earnings expectations have been revised downwards -- chopped by over 35% on the TSX. This is still going to be attractive relative to bond yields. He thinks gold could see further moves higher, perhaps over $2650. Canadian gold producers are reaping improved cash flows thanks to a weakening CAD exchange rate. He thinks low real interest rates will continue, making gold a good asset to hold going forward.

They have a satelite based location system for airlines. The software can also monitor mechanical efficiencies. Although there are not a lot of planes flying today, when they return this will be a valuable tool. They have over 3 million flying hours in testing. Within 6 months he expects contracts to be awarded due to increased regulations. He does not own it yet.

One of the Top Picks he made at $0.42 previously. A pain medication that does not burn a hole in your stomach. They have completed a test of over 300 patients in Canada that is expected by end-June. If successful, the stock should be trading north of $1. He owns over 200,000 shares.

They provide camera systems for school buses, trains, etc. They are working on a large contract in Philadelphia for $6.2 million, which would boost sales to $17-$19 million. They are working on an update of existing systems that could also be worth another $30 million. They are also looking into lane infraction camera devices. The CEO just bought over $500,000 in share values. They could go up over $0.50 per share.

The technology is interesting, using an electric motor to increase torque. The new CEO is moving the company from an experiment towards actual contracts. Electric scooters are a great platform to introduce the technology. They have announced 5 different companies they are working with. Their cash burn is about $2 million per year and will need to do a financing in the next 12 months as they are not cash flow positive yet. If they land some contracts in the next 1-2 years, they will make some real money.

They use sonar technology to look at oil rigs for safety. They have a battery that allows longer dive time. They are selling a lot of the batteries with good success. It can be used for civilian and military uses.

He participated in their recent debenture offering. They take cement, twist it, for production of insulating cement. Their book of business is about 3 times last year sales. They are bidding on contracts worth 12 times sales. He thinks this will be well positioned for government infrastructure spending in both Canada and the US. Analyst price targets are around $1.20-$1.25 per share.

He has been a buyer at $1.22. They have plasma torches that operate at extremely high temperatures. One of their products helps in the aluminum industry and it is being used overseas. They are involved in iron ore pellet conversion for shipping and processing. They are doing testing with a large ore producer to create potential sales worldwide. He thinks 500 potential torch sales over the next few years could lead to over $1 billion in sales. This also requires maintenance service agreements. The stock has recently spiked on the prospects. There could be a potential deal with the US Navy, which might be announced in late-September.

(A Top Pick May 17/19, Down 26%) There are concerns about the airline portion of their business. He no longer owns this as it triggered his stop-loss. The market is concerned about the longevity of their dividend given the yield. Analysts have been cutting the earnings outlook as well. Yield 9%

(A Top Pick May 17/19, Down 63%) Its earnings estimates have been slashed. Most recent quarterly sales were down 23% on the year and earnings were down 82%. There is still a relatively high PE ratio. Unfortunately sales are being impacted by COVID-19.

(A Top Pick May 17/19, Down 7%) He still holds this one. He participated in a financing about four months ago. They produce tests for HPV, but unfortunately COVID-19 has taken center stage. He likes their quality assessment tests and the outlook remains positive.

It produces a drug that has been repurposed for anti-anxiety in Japan. When you look at COVID-19 and its related illnesses, the drug can be used to help with chronic cough and pneumonia. Their chronic cough trial is going into Phase II in Australia. He owns it personally.

An oil and gas producer. If you believe oil prices are going higher, then you should do okay. Analysts have cut cash flow estimates on this and there are likely better opportunities out there.

The dividend has been cut. Analysts expect earnings to return next year. He is not sure if they can achieve their targets.

Earnings growth is expected to fall 22% this year. They have an ROE of 38% and the dividend is 4.6% seems to be well covered. Iron ore prices are supportive for the next few years, he thinks. If you own it, be happy. It might we a worthwhile speculative buy.